ANTI-P-SELECTIN ANTIBODY FORMULATION

摘要

The present invention relates to a stable liquid pharmaceutical formulation comprising 40 mg/ml to 200 mg/ml of an antibody against P-selectin; 0.01 % to 0.1% of a poloxamer; 5 mM to 00 mM of a buffer; and 100 mM to 500 mM of at least one stabilizer; at a pH in the range from 4.5 to 7.0.